OXiGENE, Inc.Waltham, MA, United States (NASDAQ (GM): OXGN)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

Company Description

OXiGENE starves cancer to death. The company's lead drug candidate, Zybrestat, works by disrupting the functioning of blood vessels that deliver...

Headquarters:

230 3rd Ave.
Waltham, MA 02451
United States  (Map)

Key OXiGENE Financials

Company Type Public - NASDAQ (GM): OXGN
Main Headquarters
Fiscal Year-End December
2007 Sales (mil.) $0.0
2005 Employees 26

Competition

Competitive Landscape for Chemicals

Demand is driven by the health of the US economy because chemicals are used to make a wide variety of industrial and consumer products. The profitability of individual companies is closely tied to...

Top OXiGENE Competitors

OXiGENE Executives

Title Name & Bio Contact
Chairman Joel Tomas Citron Network | E-mail
President, CEO, and Director Richard Chin Network | E-mail
VP and CFO James B. Murphy Network | E-mail
Are You Listed On Hoover's?
Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record.
Tools from our advertising partners:
Download Webinar  Free Online Trial

Sponsored Opportunity